@thelowcarbconsultant's creatine claim needs context

What does this video actually claim?

Max Helmer calls creatine "the number 1 supplement everyone should be using" in his Instagram post promoting a podcast episode with Dr. Jonathan Schoeff. The video focuses on optimization medicine, hormone balance, and peptide therapy, using creatine as a hook to discuss broader health topics.

The post doesn't provide specific evidence for the creatine claim. Instead, it transitions quickly to discussing peptides like BPC-157, testosterone optimization, and what they call "elite health and performance." This is classic supplement marketing: make a bold claim upfront, then pivot to selling more expensive interventions.

Does the science actually support this claim?

Creatine monohydrate does have solid research backing, but calling it the "number 1" supplement overstates the case. The International Society of Sports Nutrition's 2017 position statement (Kreider et al.) found creatine increases power output by 5-15% in high-intensity, short-duration activities.

A 2022 systematic review by Avgerinos et al. in Experimental Gerontology showed creatine improved cognitive function in older adults, with effect sizes ranging from 0.18 to 0.50. That's modest, not miraculous. The cognitive benefits are most pronounced in vegetarians and older populations who typically have lower baseline creatine levels.

For muscle mass, creatine adds about 1-2 kg of lean body mass over 6-8 weeks when combined with resistance training. It's effective, but fish oil, vitamin D, and protein powder could make equally strong cases for "number 1" status depending on your goals and deficiencies.

What's the real story with optimization medicine?

The video promotes "optimization medicine" and peptide therapy, which are largely unregulated wellness trends rather than evidence-based medicine. BPC-157, mentioned in the hashtags, has shown promise in animal studies but lacks human clinical trials for any condition.

This is where Helmer's content becomes problematic. While creatine is relatively well-studied, he's using it as a gateway to promote peptides and hormone treatments that don't have FDA approval for the uses he suggests. The peptide market is essentially the wild west, with compounds sold through "research chemical" loopholes.

Testosterone therapy does have legitimate medical uses for clinically diagnosed hypogonadism (levels below 300 ng/dL on multiple tests). But the "optimization" crowd often promotes hormone manipulation for normal, healthy men seeking marginal performance gains.

What should you actually know about creatine?

Creatine monohydrate is one of the most researched supplements, with over 500 peer-reviewed studies. The standard dose is 3-5 grams daily, with no need for loading phases despite what supplement companies claim. It costs about $20 for a year's supply.

The supplement works by increasing phosphocreatine stores in muscles, allowing for slightly more ATP regeneration during short bursts of intense exercise. About 30% of people are "non-responders" due to genetic variations in creatine transporter proteins.

Side effects are minimal: possible water retention and rare reports of kidney issues in people with pre-existing kidney disease. The claims about cognitive benefits are intriguing but not strong enough to recommend creatine primarily as a nootropic. If you lift weights or do high-intensity exercise regularly, creatine is worth trying. If you're sedentary, save your money.